- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2017
- Public Summary Document (PSD) March 2017 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2017 PBAC Meeting - Word
Ranolazine – March 2017
Ranolazine: Tablet (modified release) 375 mg, Tablet (modified release) 500 mg, Tablet (modified release) 750 mg; Ranexa®
Last updated
14 July 2017